Drug intelligence / Profile preview

Lymphomyosot

Development stage
Phase 2
Lead developer
Heel
Administration
Intramuscular, Subcutaneous, Intravenous, Intradermal, Oral
01

Overview

Lymphomyosot is a homeopathic complex preparation developed by Biologische Heilmittel Heel GmbH and distributed in the United States by MediNatura. It is composed of a specific mixture of botanical, mineral, and animal-derived ingredients, including *Myosotis arvensis*, *Scrophularia nodosa*, and *Aranea diadema*, prepared in homeopathic dilutions. The product is primarily indicated for the treatment of lymphatic system disorders, such as lymphoedema, and for the reduction of tissue edema and swelling associated with trauma or inflammation. While it has been marketed for over 70 years and used in clinical settings for conditions like post-traumatic edema following ankle fractures, it has recently faced regulatory scrutiny from the FDA as an unapproved new drug, leading to import restrictions and legal challenges regarding its status in the U.S. market.

Brand names
LymphomyosotLymphomyosot N
Other names
Lymphomyosot

Beyond the preview

Go deeper on Lymphomyosot.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymphomyosot.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call